<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2AFC5CFA-103A-40EE-8058-B8A79D2095DA"><gtr:id>2AFC5CFA-103A-40EE-8058-B8A79D2095DA</gtr:id><gtr:name>MRC Human Genetics Unit</gtr:name><gtr:address><gtr:line1>Western General Hospital</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH4 2XU</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2AFC5CFA-103A-40EE-8058-B8A79D2095DA"><gtr:id>2AFC5CFA-103A-40EE-8058-B8A79D2095DA</gtr:id><gtr:name>MRC Human Genetics Unit</gtr:name><gtr:address><gtr:line1>Western General Hospital</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH4 2XU</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/39A7BF7E-30F0-4EE2-8DB6-F7F639E87F1B"><gtr:id>39A7BF7E-30F0-4EE2-8DB6-F7F639E87F1B</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Meehan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127574433"><gtr:id>96FC9943-EA77-4629-B2A7-C103CBC43C49</gtr:id><gtr:title>Epigenetics and Development</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127574433</gtr:grantReference><gtr:abstractText>Our DNA encodes the central core of genetic information of the cell, which is dictated by the order of the four bases: adenine, cytosine, guanine and thymine. Throughout development, there are distinct patterns of gene expression at different stages and cell types. Consequently, there must be a level of information apart from the primary DNA sequence that specifies the selective use of genetic information in different cells. A modified base, 5-methylcytosine (5mC), is found on DNA that exhibits distinct patterns between different cells. The presence of 5mC at genes can result in gene silencing.||We are trying to understand the mechanisms by which the enzymes that introduce methylation onto DNA cause gene silencing during animal development and why the modified base, 5mC, is necessary for cellular stability? The importance of 5mC is underlined by the observation that many cancers and rare human diseases have altered patterns of DNA methylation compared to normal cells.||To understand the role of DNA methylating enzymes in cells, we produce cells lacking these enzymes and characterise what happens at the molecular level. In this way, we hope to understand the role of this important process in development and disease.</gtr:abstractText><gtr:technicalSummary>Epigenetics describes the variation of gene expression that is not due to changes in the DNA sequence. It is an important process during animal early development for setting up and maintaining stable patterns of gene transcription in adult tissues. In essence it describes how modification of chromatin or DNA regulates a genes activity.||Our main interest is determining the interplay between chromatin and DNA based silencing mechanisms in maintaining gene silencing during early animal development? We have made some exciting discoveries establishing the importance of epigenetic regulators in determining the onset of transcription during early development in amphibians, and how mis-regulation of these processes may lead to apoptosis and subsequent alterations in cellular identity and development.||The maintenance cytosine methyltransferase, xDnmt1, is responsible for maintaining high levels of DNA methylation in development. We have shown that it also acts as a direct transcription repressor protein, independently of its catalytic function, in early embryos. In addition we have identified a potential pathway though which loss of xDnmt1 function results in direct activation of a cell death pathway.||We believe our findings have important implications for the molecular basis of diverse human diseases in which epigenetic regulation is altered and potentially an understanding of the nature of cellular potency (stem cells). Our work may also contribute to the development of safe health care applications such as small molecule inhibitors of Dnmt1 function.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2749283</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Innovative Medicines Initiative (IMI)</gtr:department><gtr:description>MARCAR (Mechanism-driven development of early biomarkers and molecular tumor classification for non-genotoxic carcinogenesis)</gtr:description><gtr:id>EAE035F7-C7D4-40D9-A4BA-793B422D12B9</gtr:id><gtr:impact>I am part of a consortium (MARCAR) that after a competitive application process, has been selected by the Innovative Medicines Initiative (IMI) to negotiate a 3-5 year program of work that aims to improve the predictivity of safety evaluation in non-genotoxic carcinogenesis. We proposed a research program that includes epigenetic analysis of novel model systems and unique archived material of industrial partners (EFPIA). If the application proceeds successfully, there will be matching (in-kind) funds from EFPIA members. An ultimate aim of the research program is to identify new biomarkers for non-genotoxic carcinogenesis in liver.</gtr:impact><gtr:outcomeId>6B28CEEFDA1-1</gtr:outcomeId><gtr:partnerContribution>I am part of a consortium (MARCAR) that after a competitive application process, has been selected by the Innovative Medicines Initiative (IMI) to negotiate a 3-5 year program of work that aims to improve the predictivity of safety evaluation in non-genotoxic carcinogenesis. We proposed a research program that includes epigenetic analysis of novel model systems and unique archived material of industrial partners (EFPIA). If the application proceeds successfully, there will be matching (in-kind) funds from EFPIA members. An ultimate aim of the research program is to identify new biomarkers for non-genotoxic carcinogenesis in liver.European networking, the application of epigenetics to toxicology testing. New interaction with NHI (US) funded agencies and colleagues. The successful application for Funding from IMI (EU) to commence in January 2009.</gtr:partnerContribution><gtr:piContribution>I am part of a consortium (MARCAR) that after a competitive application process, has been selected by the Innovative Medicines Initiative (IMI) to negotiate a 3-5 year program of work that aims to improve the predictivity of safety evaluation in non-genotoxic carcinogenesis. We proposed a research program that includes epigenetic analysis of novel model systems and unique archived material of industrial partners (EFPIA). If the application proceeds successfully, there will be matching (in-kind) funds from EFPIA members. An ultimate aim of the research program is to identify new biomarkers for non-genotoxic carcinogenesis in liver.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Workshop at Syngenta, Bracknell, UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FC108DC3-FC8B-4D52-9C35-59EE851F4063</gtr:id><gtr:impact>Discussion on the role of environmental toxins that may be epigenetic modifiers.

Resulting invitations to speak and lead discussions at Transgenerational epigenetics workshop organised by Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) 7th February 2008. The 2009 National Academy Sciences Environmental Epigenetics Workshop, Washington, July 30-31. The HESI WORKSHOP ON THE STATE OF THE SCIENCE OF EPIGENETICS OCTOBER 28-30, 2009, North Carolina, USA. Contributed to participation in MARCAR, which will study early epigenetic changes in response to non-genotoxic carcinogenes.</gtr:impact><gtr:outcomeId>79AF4BFB142</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ICE-2008: Oral presentation and member of review panel</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>57D2DB2E-717A-48C1-AB80-E51F51F9AE17</gtr:id><gtr:impact>The ICE-2008 is the final conference of the priority program SPP1129 of the Deutsche Forschungsgemeinschaft (funding period 2002 - 2008) for which I was an external reviewer. The conference is funded by the Deutsche Forschungsgemeinschaft (DFG).

Forged new links between DFG grant holders and UK (mainly BBSRC) funded researchers on epigenetics.</gtr:impact><gtr:outcomeId>79DED9B6F02</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://epigenetics.uni-saarland.de/en/spp1129/</gtr:url><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CoTox Transgenerational epigenetics workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0AAD1D0F-A326-44EA-B224-57206EF566F2</gtr:id><gtr:impact>Discussion on the role of environmental toxins that may be epigenetic modifiers, with a view to the impact on human health.

Resulting invitations to speak and lead discussions at The 2009 National Academy Sciences Environmental Epigenetics Workshop, Washington, July 30-31. The HESI WORKSHOP ON THE STATE OF THE SCIENCE OF EPIGENETICS OCTOBER 28-30, 2009, North Carolina, USA. Contributed to participation in MARCAR, which will study early epigenetic changes in response to non-genotoxic carcinogenes.</gtr:impact><gtr:outcomeId>036E9FF9776</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HESI, North  Carolina</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4DE347E5-600D-449D-878E-8135A38ED842</gtr:id><gtr:impact>150 ; General audience of scientists, including toxicologists, precipitating many questions on the possibility of environmental exposure leading to disruption of epigenetic pathways.

Planning of future experiments with a view to testing new ideas in 2010 and 2011</gtr:impact><gtr:outcomeId>iiS8KHADihQ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dundee Personalised Medicine meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>861A50BF-721F-4C70-90A2-EBE65C1D98BB</gtr:id><gtr:impact>Discussions with Clinicians and non-clinicians on the role of Epigenetics in disease and as a potential biomarker

New collaborations ensued</gtr:impact><gtr:outcomeId>KDdAAeKe3Ju</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Syngenta Sponsored Workshop on Epigenetics - 24th - 25th September 2007</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>73C67E6F-76AA-40F6-AEDA-7C27C0474DE2</gtr:id><gtr:impact>Discussion of the possibility that exposure to certain compounds may result in epigenetic dysregulation.

Brain storming session on the role of epigenetics in toxicology assessment and exposure.</gtr:impact><gtr:outcomeId>1DEE5AD821C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chair and platform speaker European Epigenetics meeting. 14-15th September, Dublin, Ireland.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7F865F7C-D0BC-461E-B93F-3E69A85FE2C6</gtr:id><gtr:impact>Discussions with lifscience stakeholder on the role of Epigenetics in disease and as a potential biomarker for drug exposure

New collaborations ensued</gtr:impact><gtr:outcomeId>M9b6uVzvyrA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HUGO 2007 Platfom Speaker Symposium IV</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>130B8891-D88A-440B-8E4F-03A2D9159239</gtr:id><gtr:impact>The scientific programme for HGM2007 to an international audience of scientists and clinicians was focussed on worldwide progress in the Human Genome Project and the programme included sessions on: &amp;middot; Large-Scale Medical Resequencing &amp;middot; Genome Wide Association Studies in depth analysis of the human genome &amp;middot; Genomic Variation &amp;middot; Genomic Medicine - Global Perspectives &amp;middot; Regulatory RNAs &amp;middot; Epigenomics &amp;middot; Genetics of Infectious Diseases &amp;middot; Neuropsychiatric Genetics I spoke in the Epigenomics session

Theconference was reported on daily by national (Canada) and international media sources.</gtr:impact><gtr:outcomeId>947E71FBEBA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rome: Epigenetics and Chemical Safety</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BBCD6DBB-7C62-4874-84B6-88CF3A363C15</gtr:id><gtr:impact>The workshop addressed the following aspects:

 examine scientific and technological approaches to identify and quantify epigenetic effects of chemicals and to assess their potential effects on human health and ecology.

 consider the strengths and weaknesses and the costs and benefits of looking at epigenetic effects of chemicals by using new approaches and technologies.

In particular the workshop addressed the following points:

 Definition of epigenetic changes and effects in the context of (eco-) toxicology.
 What are the consequences of epigenetic changes induced by exogenous substances on human and environmental health?
 Is the current way of assessing the safety of chemicals able to detect adverse effects related to epigenetic changes?
 Case studies: implications of epigenetics in adverse effects in Humans, in animal models and ecotoxicology


WE produced a report.
http://www.ecetoc.org/index.php?mact=MCSoap,cntnt01,details,0&amp;amp;cntnt01by_category=22&amp;amp;cntnt01order_by=date%20Desc&amp;amp;cntnt01template=display_list_v2&amp;amp;cntnt01display_template=display_details_v2&amp;amp;cntnt01document_id=6329&amp;amp;cntnt01returnid=59

WR 23 : ECETOC WR 23 - Epigenetics and Chemical Safety | 18 June 2012

Epigenetics is a rapidly developing and expanding biological science which will change our perception of cell biology in a profound way. In order to increase our knowledge of how epigenetics could have an impact in (eco)toxicology, a solid understanding of the biology and variation of the epigenome is essential to better assess concerns about possible adverse health effects related to epigenetic changes.</gtr:impact><gtr:outcomeId>sFykiEPQHKS</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.ecetoc.org/index.php?mact=XtendedCalendar,cntnt01,details,0&amp;cntnt01documentid=41&amp;cntnt01returnid=108</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Next-Gen Sequencing Europe conference Hamburg, June 30</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E7E0D347-4FE4-4CD3-859F-08D405C6E2F6</gtr:id><gtr:impact>THe of a new 6th base, 5-hydroxymethylcytosine, on epigenetics

New collaborations ensued</gtr:impact><gtr:outcomeId>KyunVLWFm42</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Washington National Acadamey</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8A8781BA-E751-471C-9AA2-CE533B5315F9</gtr:id><gtr:impact>100 stake holders (including science media) attanded with a subsequent Q and A session

Subsequent invite to HESI workshop on the state of the science of epigenetics in North Carolina</gtr:impact><gtr:outcomeId>pmdAv2MT6Js</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>47th Congress of the European Societies of Toxicology. August 28-31,</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D92096AD-C3BC-42B0-9DFD-E2F5EC11B81E</gtr:id><gtr:impact>Epigenetics as a biomarker for drug exposure

New collaborations developed</gtr:impact><gtr:outcomeId>GBwVtnz7mSX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FEBS Workshop Denmark</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A2878B5E-88F0-4595-A664-18DD42DF22C5</gtr:id><gtr:impact>I presented two lectures; one present trends in Epigenetics Research and a second on my own research programs.

My talks stimulated much debate and questions.</gtr:impact><gtr:outcomeId>thSpGhMNtgv</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>5hmC Workshop Biochem Soc</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6CCBFE3F-3FE8-4FD3-9699-B19934A6F6C2</gtr:id><gtr:impact>The New Epigenetic Mark: 5-Hydroxymethylcytosine - What is its Function?
13 June 2013: Cancer Research UK Cambridge Institute, UK
Title: Knowing me, Knowing you. Ahaaaa! 5hmC and the Epigenetics of identity


I made a you tubre presentation to explain the topic.

http://www.youtube.com/watch?v=0EXzIOw4hNg</gtr:impact><gtr:outcomeId>oDEGjQAnynd</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.biochemistry.org/tabid/379/MeetingNo/HT006/view/Programme/default.aspx</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>COTOX Presentation and subsequent review of the resulting report</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6F0732FE-3925-411F-B796-044B30082655</gtr:id><gtr:impact>An oral presenation to the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) at its meeting in Prestbury, near Manchester on 6 February 2008. This presentation would included an introduction to epigenetics together with consideration of the role of DNA methylation in development, disease and its perturbation by environmental toxins. Feed back was positive and resulted in a written report statement on the Transgenerational Epigenetics workshop has now published on the Committee's website - see the link below. http://cot.food.gov.uk/cotstatements/cotstatementsyrs/cotstatements2008/cot200803

COT Conclusions 46. There is reasonable evidence that epigenetic changes associated with environmental exposures during development can result in adverse effects. Such effects might be detected in the F1 and F2 generations by standard regulatory toxicity testing. 47. Transgenerational epigenetic inheritance of effects in the F3 generation and beyond would also be of potential relevance to risk assessment. If epigenetic inheritance does occur, it is possible that this could lead to an accumulation in risk across generations. In addition, such epigenetic changes could be developed as biomarkers of effect. 48. However, the science is not yet developed and therefore assessment of transgenerational epigenetic inheritance cannot be incorporated in regulatory risk assessment at present. 49. It is still unclear whether transmission of environmentally acquired epigenetic changes across generations occurs in humans and if so, what mechanisms of epigenetic modification are important. 50. Priorities for future research include assessment of whether important examples of epigenetic inheritance seen in animals also occur in humans. In addition, it may be useful to investigate aberrant phenotypes in humans which might possibly have a transgenerational, epigenetic basis. It is feasible to undertake genome wide profiling to ascertain if changes in DNA methylation patterns underlie environmentally acquired epigenetic changes that occur in experimental models and perhaps human populations.</gtr:impact><gtr:outcomeId>B38B22AD85A</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:url>http://cot.food.gov.uk/cotstatements/cotstatementsyrs/cotstatements2008/cot200803</gtr:url><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2006 Taiwan Society for Stem Cell Research</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1C95816F-7A88-4DD2-B9FF-73256DAA9A66</gtr:id><gtr:impact>I attended and spoke at the Annual meeting for &amp;quot;Taiwan Society for Stem Cell Research&amp;quot;.I presented a lecture on my work on epigenetics and development. The meeting was directly related to the goal of my present work in terms of understanding cellular pluipotency and the stability of epigenetic mechanisms in stem cells and development. It was a great opportunity to meet with fellow workers and world experts in the field and to reciprocate the visit of a Taiwanese delegation to Scotland that was held on October 2005.

The conference was a major news item in Taiwan and at the conference a new programm of research was annouced by the Taiwanese minster for Science.</gtr:impact><gtr:outcomeId>3ACB3D746ED</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop on Epigeneticsand Chemical Safety</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>02C853C9-4004-442B-B2B7-07E70F1CC0FB</gtr:id><gtr:impact>My talk on new methods for assessing epigentic perturnations was well received and stimulated much debate and questions.

We produced a report that was published in 2012 that was entitled 'Epigenetics and Chemical Safety'.</gtr:impact><gtr:outcomeId>Z7PT8DuX9uq</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2009 Rank Prize Fund (Nutritional Epigenomics),</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A44B22C9-D0B1-4CF2-8E97-14C9470C1078</gtr:id><gtr:impact>Discussion on the role of environmental toxins that may be epigenetic modifiers.

Still on-going</gtr:impact><gtr:outcomeId>1147FA84C66</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Hydroxy-Sensitive Cut Counting (HSCC); simultaneous, genome-wide mapping of 5-methylcytosine and 5-hydroxymethylcytosine in mammals</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/J021032/1</gtr:fundingRef><gtr:id>42FB3E73-59E5-4ADF-92F6-DFDFF33A27FD</gtr:id><gtr:outcomeId>G3y6AcXYYs8</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Epigenetic Landscape Global Nuclear Positioning Tools</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K01384X/1</gtr:fundingRef><gtr:id>9F4DDD2C-A78E-4CCA-BA72-BFC17E2FA356</gtr:id><gtr:outcomeId>PtdeHMcSuBD</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Research Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/E023355/1</gtr:fundingRef><gtr:id>39B95678-9304-4035-977E-B7515DEA7692</gtr:id><gtr:outcomeId>DC0473344D90</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Mechanisms underlying the transmission of programming effects</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K018310/1</gtr:fundingRef><gtr:id>CF009744-B966-4088-B63A-2F44C9DE5C39</gtr:id><gtr:outcomeId>EYPpS8mZzEx</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Breakthrough Breast Cancer Research Unit</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Breakthrough Breast Cancer</gtr:fundingOrg><gtr:id>DB3AECED-10D8-4E90-A759-C775C584FA10</gtr:id><gtr:outcomeId>F419CF8068D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The present invention relates to methods of identifying genes which are primarily and causally regulated by epigenetic events such as, for example, DNA methylation. The invention also provides uses of such genes and transgenic animals.</gtr:description><gtr:grantRef>MC_U127574433</gtr:grantRef><gtr:id>D9068265-88F3-43ED-8AF6-A379BE00A6A3</gtr:id><gtr:impact>Too early to say</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>NSF8mtRjDSd</gtr:outcomeId><gtr:patentId>GB1014818.7</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Gene regulation</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>The Epigenome Network of Excellence (NoE)</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>9153865E-1784-417B-B307-F5B528C0E404</gtr:id><gtr:outcomeId>10E7D1FB389</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Epigenetics and Chemical Safety ; Rome</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D2D0F01C-4922-4560-91D5-6189AF77E015</gtr:id><gtr:outcomeId>K3vmtPQW7L4</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://www.ecetoc.org/eventsmanager/20/258/Epigenetics-and-Chemical-Safety/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EpiGeneSys</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>5AA23B8E-8B8B-4E9C-A433-A0B62DE10A3F</gtr:id><gtr:outcomeId>tk9nyAVzmM6</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.epigenesys.eu/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Science Foudation Ireland</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>43A66DB0-CF97-41C2-ABFF-E4FBC67DFF9B</gtr:id><gtr:outcomeId>g2MtcRFxkaW</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>External Reviewer Epigentics Panel for DFG (German research Council)</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>F5429046-E2F1-485E-979F-CD2BA0B9E63D</gtr:id><gtr:outcomeId>917020304C9</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>217D954E-B6A0-43C6-98AC-8D845D3F7CC7</gtr:id><gtr:outcomeId>CF01C6CB1B6</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://cot.food.gov.uk/cotstatements/cotstatementsyrs/cotstatements2008/cot200803</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Danish Research Foundation Site Review Panel member</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>CDE667E6-09DC-4561-BDED-2ECE7F948DC8</gtr:id><gtr:outcomeId>VtiatKJaL17</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We developed a technique to map athe newly modified base 5-hydroxymethylcytosine in geneomic DNA.</gtr:description><gtr:id>FA58AEB5-39EC-4DD6-AF09-F2D6DBDFBD02</gtr:id><gtr:impact>3 high impact publications, with more to follow.</gtr:impact><gtr:outcomeId>Br9qjdjByQs</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>H-DIP</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://genomebiology.com/content/13/10/R93</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Expression clones for Xenopus Dnmt1.</gtr:description><gtr:id>8C733B5D-97E4-4265-B796-F31D3AE80DDD</gtr:id><gtr:impact>We identified a signaling pathway by which apoptosis is induced in XDnmt1 depleted embryos. we believe this is an important pathway that is not fully functional in cancer cells that have an altered DNA methylation profle as a result of mis-regulation of DNMT1.</gtr:impact><gtr:outcomeId>E380C5D4F83</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Non-canonical roles for DNMT1</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed a 'recovery' assay that allows identification of genes that are strictly regulated by DNA methylation through exposure to epigenetic disruptors.</gtr:description><gtr:id>D0F8E024-AA9E-45EF-9E7B-5CF5A5261DE1</gtr:id><gtr:impact>Too early to say</gtr:impact><gtr:outcomeId>jPwb4yo4LMk</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Indentification of genes regulated directly by DNA methylation</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:url>http://dev.biologists.org/content/139/19/3623.long</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>1. Dynamic changes in liver 5-hydroxymethylcytosine profiles upon non-genotoxic carcinogen exposure [Replicated control vs. pb treated study]
(Submitter supplied) Dynamic changes in the mouse liver DNA methylome associated with short (1 day) and prolonged (7, 28 and 91 days) exposure to the rodent liver non-genotoxic carcinogen (NGC), phenobarbital (PB).
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL1261 39 Samples
FTP download: GEO (CEL) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE45nnn/GSE45465/
Series Accession: GSE45465 ID: 200045465

2. Gene expression in E18.5 Tex19.1-/- mouse placenta
(Submitter supplied) Microarray experiment to identify changes in gene expression in 18.5 day post coitum Tex19.1-/- mouse placenta. Tex19.1 is expressed in trophectoderm-derived cells in the placenta. Tex19.1-/- placentas are small and have defects in junctional zone and labyrinth layers of the placenta, Tex19.1-/- embryos exhibit intra-uterine growth retardation. Data provides insight into the changes in gene expression and cell composition in Tex19.1-/- placentas.
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6887 12 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE41nnn/GSE41823/
Series Accession: GSE41823 ID: 200041823

3. Reduced Representation Bisulfite Sequencing in DNA methylation deficient mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Methylation profiling by high throughput sequencing
Platform: GPL13112 2 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44760/, SRA SRP018930 ftp://ftp-trace.ncbi.nlm.nih.gov/sra/sra-instant/reads/ByStudy/sra/SRP/SRP018/SRP018930/
Series Accession: GSE44760 ID: 200044760

4. DNA methylation profiling by HELP-seq in Dnmt1+/+ mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Methylation profiling by high throughput sequencing
Platform: GPL9250 1 Sample
FTP download: GEO (BEDGRAPH) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44757/, SRA SRP018929 ftp://ftp-trace.ncbi.nlm.nih.gov/sra/sra-instant/reads/ByStudy/sra/SRP/SRP018/SRP018929/
Series Accession: GSE44757 ID: 200044757

5. mRNA-seq in DNA methylation deficient mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Expression profiling by high throughput sequencing
Platform: GPL13112 2 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44733/, SRA SRP018928 ftp://ftp-trace.ncbi.nlm.nih.gov/sra/sra-instant/reads/ByStudy/sra/SRP/SRP018/SRP018928/
Series Accession: GSE44733 ID: 200044733

6. Chip-seq for H3K27me3 and H3K4me3 in DNA methylation deficient mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Genome binding/occupancy profiling by high throughput sequencing
Platform: GPL11002 4 Samples
FTP download: GEO (BEDGRAPH) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44393/, SRA SRP018761 ftp://ftp-trace.ncbi.nlm.nih.gov/sra/sra-instant/reads/ByStudy/sra/SRP/SRP018/SRP018761/
Series Accession: GSE44393 ID: 200044393

7. Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of polycomb-target genes
(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism: Mus musculus
Type: Expression profiling by array; Genome binding/occupancy profiling by genome tiling array; Methylation profiling by high throughput sequencing; Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
6 related Platforms 35 Samples
FTP download: GEO (BEDGRAPH, PAIR) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44278/
Series Accession: GSE44278 ID: 200044278

8. Comparison of gene expression in Dnmt1+/+ and Dnmt1-/- MEFs
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6887 6 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44277/
Series Accession: GSE44277 ID: 200044277

9. Comparison of gene expression in Dnmt1+/+ MEFs treated with 5-aza-2'-deoxycytidine or vector control
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6885 8 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44276/
Series Accession: GSE44276 ID: 200044276

10. Chip-chip for H3K27me3 and H3K4me3 in DNA methylation deficient mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Genome binding/occupancy profiling by genome tiling array
Platform: GPL16605 12 Samples
FTP download: GEO (PAIR) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44149/
Series Accession: GSE44149 ID: 200044149

11. IP of 5-methylcytosine (5-mC) enriched DNA fragments from control and PB treated mouse livers (28 day)
(Submitter supplied) 5-mC is an epigenetic modification of the DNA base cytosine with roles in gene silencing events, imprinting and X inactivation. Phenobarbital (PB) is a well studied non-genotoxic carcinogen with roles in epigenetic perturbation. We profile 5mC in both control mouse livers as well as in the livers of 28 day PB treated mice. 5mC is largely found to reside in the bodies of active genes and promoter levels are perturbed upon PB induced gene activation events. more...
Organism: Mus musculus
Type: Methylation profiling by genome tiling array
Platform: GPL14890 10 Samples
FTP download: GEO (PAIR, TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE40nnn/GSE40538/
Series Accession: GSE40538 ID: 200040538

12. IP of 5-hydroxymethylcytosine (5-hmC) enriched DNA fragments from control and PB treated mouse livers (28 day)
(Submitter supplied) 5-hmC is a novel epigenetic mark derived from oxidation of methylcytosine. Phenobarbital (PB) is a well studied non-genotoxic carcinogen with roles in epigenetic perturbation. We profile 5hmC in both control mouse livers as well as in the livers of 28 day PB treated mice. 5hmC is largely found to reside in the bodies of active genes and promoter levels are perturbed upon PB induced gene activation events. more...
Organism: Mus musculus
Type: Methylation profiling by genome tiling array
Platform: GPL14890 10 Samples
FTP download: GEO (PAIR, TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE40nnn/GSE40537/
Series Accession: GSE40537 ID: 200040537

13. IP of 5-hydroxymethylcytosine (5-hmC) and 5-methylcytosine (5-mC) enriched DNA fragments from control and PB treated mouse livers
(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism: Mus musculus
Type: Methylation profiling by genome tiling array; Expression profiling by array; Genome binding/occupancy profiling by high throughput sequencing
6 related Platforms 153 Samples
FTP download: GEO (BEDGRAPH, CEL, PAIR) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE40nnn/GSE40540/
Series Accession: GSE40540 ID: 200040540

14. Dynamic changes in liver 5-hydroxymethylcytosine profiles upon non-genotoxic carcinogen exposure
(Submitter supplied) 29-32 days old male mice where either treated with Phenobarbital or untreated
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL1261 10 Samples
FTP download: GEO (CEL) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE40nnn/GSE40773/
Series Accession: GSE40773 ID: 200040773

15. Promoter DNA methylation couples genome-defense mechanisms to epigenetic reprogramming in the mouse germline
(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism: Mus musculus
Type: Expression profiling by array
Platforms: GPL6885 GPL6887 5 Samples
FTP download: GEO ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE38nnn/GSE38307/
Series Accession: GSE38307 ID: 200038307</gtr:description><gtr:id>FD408F8D-C6DB-4328-88B4-63D51A37EBCB</gtr:id><gtr:impact>Available for Meta analysis by other groups</gtr:impact><gtr:outcomeId>CBjJoW1DEGb</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Data Sets Generated by work</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/gds</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>16. Promoter DNA methylation couples genome-defense mechanisms to epigenetic reprogramming in the mouse germline (part 2)
(Submitter supplied) Mouse primordial germ cells (PGCs) erase global DNA methylation (5mC) as part of the comprehensive epigenetic reprogramming that occurs during PGC development. 5mC plays an important role in maintaining stable gene silencing and repression of transposable elements (TE) but it is not clear how the extensive loss of DNA methylation impacts on gene expression and TE repression in developing PGCs. Using a novel epigenetic disruption and recovery screen and genetic analyses, we identified a core set of germline-specific genes that are dependent exclusively on promoter DNA methylation for initiation and maintenance of developmental silencing. more...
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6885 2 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE38nnn/GSE38306/
Series Accession: GSE38306 ID: 200038306

17. Promoter DNA methylation couples genome-defense mechanisms to epigenetic reprogramming in the mouse germline (part 1)
(Submitter supplied) Mouse primordial germ cells (PGCs) erase global DNA methylation (5mC) as part of the comprehensive epigenetic reprogramming that occurs during PGC development. 5mC plays an important role in maintaining stable gene silencing and repression of transposable elements (TE) but it is not clear how the extensive loss of DNA methylation impacts on gene expression and TE repression in developing PGCs. Using a novel epigenetic disruption and recovery screen and genetic analyses, we identified a core set of germline-specific genes that are dependent exclusively on promoter DNA methylation for initiation and maintenance of developmental silencing. more...
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6887 3 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE38nnn/GSE38305/
Series Accession: GSE38305 ID: 200038305

18. Gene expression in 16 dpp Tex19.1-/- mouse testes
(Submitter supplied) Microarray experiment to identify changes in gene expression in 16 day post partum prepubertal Tex19.1-/- mouse testes. Tex19.1 is expressed in germ cells in testes. Tex19.1-/- mice have spermatogenic defects and errors in progression through meiosis. Data provides insight into the changes in gene expression in developing testes at the time when meiotic defects first start to become apparent.
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6887 8 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE30nnn/GSE30461/
Series Accession: GSE30461 ID: 200030461

19. Hydroxymethyl DNA-IP of genomic DNA for many different normal human tissues
(Submitter supplied) 5-hmC is a novel epigenetic mark derived from oxidation of methylcytosine. We profile this mark in several normal human tissues 5-hmC patterns are highly tissue specific and enriched in the body of transcribed genes 5-hmC patterns are highly tissue specific and enriched in the body of transcribed genes
Organism: Homo sapiens
Type: Methylation profiling by genome tiling array
Platform: GPL14788 14 Samples
FTP download: GEO (PAIR) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE33nnn/GSE33219/
Series Accession: GSE33219 ID: 200033219

20. Analysis of Promoter Methylation in Breast Cancer
(Submitter supplied) Promoter methylation was assayed in a number of breast cancer and control normal samples along with the effects of 5'-aza-2'-deoxycytidine on breast cancer cell line transcriptomes. Aberrant promoter hypermethylation is frequently observed in cancer. The potential for this to contribute to tumour development depends on whether the genes affected are repressed because of their methylation. Many aberrantly methylated genes play important roles in development and are bivalently marked in ES cells suggesting that their aberrant methylation may reflect developmental processes. more...
Organism: Homo sapiens
Type: Methylation profiling by array; Expression profiling by array
Platforms: GPL8490 GPL6947 107 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE26nnn/GSE26990/
Series Accession: GSE26990 ID: 200026990</gtr:description><gtr:id>3CB824CD-3B77-4B5A-9F74-EF5DA92897DF</gtr:id><gtr:impact>Avaialable for Meta analysis by other groups</gtr:impact><gtr:outcomeId>nRayeJAJWa7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Data sets Part II</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/gds</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>WE constructed cells containing a methylated silenced gene lined to a GFP reporter. If the methylation is removed then the gene is active and the cells turn green. Potentially useful for drug screens.</gtr:description><gtr:id>E855B741-651C-4F5D-A25E-5659976E5C0A</gtr:id><gtr:impact>An in vivo reporter for DNA methyltransferase inhibitors.</gtr:impact><gtr:outcomeId>qSkLzjZBHEn</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>DNA methylation inhibitor reporter</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>During my post-doctral career I identified and characterised the first methyl-CpG binding activities and subsequently methyl-CpG binding protein, MeCP2. These factors fitted a model whereby cytosine methylation at promoter sequences can result in gene silencing that is mediated by the binding of these proteins at promoter proximal regions. Now there are several methyl-CpG binding proteins. We identified the methyl-CpG-binding motif (MBD domain) of MeCP2 and its structure has subsequently been determined by nuclear magnetic resonance analysis. The domain adopts a wedge-shaped structure containing a four-stranded antiparallel &amp;szlig; sheet at the amino terminus as one face and a helical region at the carboxy terminus as another face. This finding suggested that methyl-CpG binding proteins do not have a sequence preference in vitro and this property has been used to selectively enrich for in vivo or in vitro methylated sequences.</gtr:description><gtr:id>44804CBF-0C45-44C7-8900-FFD2197D6FC9</gtr:id><gtr:impact>Either for direct sequencing and analysis or for screening arrays to identify methylated sequences that occur during normal development or that have occurred de novo in cancer.</gtr:impact><gtr:outcomeId>4B3F4FC4971</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>methyl CpG binding proteins</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FF78972A-B37C-4A33-90DD-E1B496D1E6D3</gtr:id><gtr:title>Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA.</gtr:title><gtr:parentPublicationTitle>BioTechniques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf699c1de6a45dbbe736650f7d5d9073"><gtr:id>cf699c1de6a45dbbe736650f7d5d9073</gtr:id><gtr:otherNames>Nestor C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0736-6205</gtr:issn><gtr:outcomeId>Jd9m4K34KiA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABB5FA4D-1A4F-448D-BCB5-3C46DFBB5EF2</gtr:id><gtr:title>Non-canonical functions of the DNA methylome in gene regulation.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/385830da8e668f868ad41509c80b3eb9"><gtr:id>385830da8e668f868ad41509c80b3eb9</gtr:id><gtr:otherNames>Reddington JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>XuCRpkJG6hd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9635B97F-FAFF-472D-AE21-1AFF6BF0B047</gtr:id><gtr:title>An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89294f6bf27bc4dafad391db6a16756e"><gtr:id>89294f6bf27bc4dafad391db6a16756e</gtr:id><gtr:otherNames>Katz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>RCwDefK2qZE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FE5DB45-9DD2-4778-85DD-8DAC85AF60D5</gtr:id><gtr:title>Comparative analysis of affinity-based 5-hydroxymethylation enrichment techniques.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>UgLVya4eiy8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DB7B487-4BC2-46B8-9505-1A67DF2C4FB3</gtr:id><gtr:title>Lsh regulates LTR retrotransposon repression independently of Dnmt3b function.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b948bbf8fb5cbdccfe5e4b4d6ad63b52"><gtr:id>b948bbf8fb5cbdccfe5e4b4d6ad63b52</gtr:id><gtr:otherNames>Dunican DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>542e75a4a5c570.64978290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DEA5E83-98A6-45AC-83F3-69B15AF9976F</gtr:id><gtr:title>Lsh Is Essential for Maintaining Global DNA Methylation Levels in Amphibia and Fish and Interacts Directly with Dnmt1.</gtr:title><gtr:parentPublicationTitle>BioMed research international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b948bbf8fb5cbdccfe5e4b4d6ad63b52"><gtr:id>b948bbf8fb5cbdccfe5e4b4d6ad63b52</gtr:id><gtr:otherNames>Dunican DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>569fa829bce982.88703160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10EAAEB9-6EE7-4752-BC93-739AD4B6364A</gtr:id><gtr:title>Investigating 5-hydroxymethylcytosine (5hmC): the state of the art.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8325dbf499f9df455860713307706458"><gtr:id>8325dbf499f9df455860713307706458</gtr:id><gtr:otherNames>Nestor CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14263_23_24162993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59B71F20-4D99-4F22-9B63-6CBE72F79D08</gtr:id><gtr:title>Hydroxymethylated DNA immunoprecipitation (hmeDIP).</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8325dbf499f9df455860713307706458"><gtr:id>8325dbf499f9df455860713307706458</gtr:id><gtr:otherNames>Nestor CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14263_23_24162994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>776A728E-63E2-4428-980B-6453458F27E3</gtr:id><gtr:title>Putting muscle in DNA methylation.</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/385830da8e668f868ad41509c80b3eb9"><gtr:id>385830da8e668f868ad41509c80b3eb9</gtr:id><gtr:otherNames>Reddington JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>fVxgyJSyob5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39EA2178-0B2F-4BEE-847F-1E1E26B986D5</gtr:id><gtr:title>Senescent cells harbour features of the cancer epigenome.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98548b7f0d172a12eb55f6751ffbd86e"><gtr:id>98548b7f0d172a12eb55f6751ffbd86e</gtr:id><gtr:otherNames>Cruickshanks HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>542e75a4123687.45712123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E70A5935-7917-4CA2-9592-A0809E370A01</gtr:id><gtr:title>The genome-defence gene Tex19.1 suppresses LINE-1 retrotransposons in the placenta and prevents intra-uterine growth retardation in mice.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6320490484abba0201d62fb40ea013cd"><gtr:id>6320490484abba0201d62fb40ea013cd</gtr:id><gtr:otherNames>Reichmann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>Qdn8CmSg1W1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BA89ACC-8AF0-4D3F-937B-8F4F47C9B968</gtr:id><gtr:title>The interaction of xKaiso with xTcf3: a revised model for integration of epigenetic and Wnt signalling pathways.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a958836c63f12cd0a15e2066eb8fcb7"><gtr:id>8a958836c63f12cd0a15e2066eb8fcb7</gtr:id><gtr:otherNames>Ruzov A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>000F9E68C70</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB086DD2-8AB6-476B-B446-CB19F51CDCEF</gtr:id><gtr:title>Microarray analysis of LTR retrotransposon silencing identifies Hdac1 as a regulator of retrotransposon expression in mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6320490484abba0201d62fb40ea013cd"><gtr:id>6320490484abba0201d62fb40ea013cd</gtr:id><gtr:otherNames>Reichmann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>pm_14263_23_22570599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15FA13EA-5D3D-46DE-BC5F-FB21112B58C4</gtr:id><gtr:title>An unbalanced maternal diet in pregnancy associates with offspring epigenetic changes in genes controlling glucocorticoid action and foetal growth.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c6a07e95c767d5396f3151e0611dfd0"><gtr:id>2c6a07e95c767d5396f3151e0611dfd0</gtr:id><gtr:otherNames>Drake AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>pm_14263_23_22642564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>467A095C-6EB2-4473-878F-1416E30C3699</gtr:id><gtr:title>Multigenerational programming in the glucocorticoid programmed rat is associated with generation-specific and parent of origin effects.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c6a07e95c767d5396f3151e0611dfd0"><gtr:id>2c6a07e95c767d5396f3151e0611dfd0</gtr:id><gtr:otherNames>Drake AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>to16fS6xq5p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFD8B65A-9AFF-4C41-AD77-652F4BEC9AB0</gtr:id><gtr:title>MBD4 and MLH1 are required for apoptotic induction in xDNMT1-depleted embryos.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a958836c63f12cd0a15e2066eb8fcb7"><gtr:id>8a958836c63f12cd0a15e2066eb8fcb7</gtr:id><gtr:otherNames>Ruzov A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>CB78B080457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10224D60-B4BA-4A29-B21D-18DD38DCA63B</gtr:id><gtr:title>Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2294dad92431bb8ee1ed5446506e3520"><gtr:id>2294dad92431bb8ee1ed5446506e3520</gtr:id><gtr:otherNames>Sproul D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_14263_23_23034185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6784785-E590-4E24-B85D-7A5D85C8F2CA</gtr:id><gtr:title>Targeting of Rac GTPases blocks the spread of intact human breast cancer.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89294f6bf27bc4dafad391db6a16756e"><gtr:id>89294f6bf27bc4dafad391db6a16756e</gtr:id><gtr:otherNames>Katz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>pm_14263_23_22689141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8974F6D-DE2C-4181-A120-1192BF77B416</gtr:id><gtr:title>Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/385830da8e668f868ad41509c80b3eb9"><gtr:id>385830da8e668f868ad41509c80b3eb9</gtr:id><gtr:otherNames>Reddington JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_14263_23_23531360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CC6E34D-0133-4EDC-AD7A-79AB8300173F</gtr:id><gtr:title>Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2294dad92431bb8ee1ed5446506e3520"><gtr:id>2294dad92431bb8ee1ed5446506e3520</gtr:id><gtr:otherNames>Sproul D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>eRVcuebLa8Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A027077D-0369-4443-8285-BB03CA28E103</gtr:id><gtr:title>5-hydroxymethylcytosine profiling as an indicator of cellular state.</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34f346386c513bb4933b76fee2a584d9"><gtr:id>34f346386c513bb4933b76fee2a584d9</gtr:id><gtr:otherNames>Laird A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>tfbDHjNyjhR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6D59A96-9AF6-441D-BA92-99EAA7AFDC9E</gtr:id><gtr:title>Reduced levels of two modifiers of epigenetic gene silencing, Dnmt3a and Trim28, cause increased phenotypic noise.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/402fbee168ce29dbac0062d8da264897"><gtr:id>402fbee168ce29dbac0062d8da264897</gtr:id><gtr:otherNames>Whitelaw NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>JVXutWMR2ZG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>401643A4-6E8D-4F8B-BEF1-C8E6CC1B75AA</gtr:id><gtr:title>From paramutation to paradigm.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cda3bf0cd53483e22837e1a4c48967cd"><gtr:id>cda3bf0cd53483e22837e1a4c48967cd</gtr:id><gtr:otherNames>Adams IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_14263_23_23717216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>093006F2-6B77-4FB2-A584-923FA31906A0</gtr:id><gtr:title>xDnmt1 regulates transcriptional silencing in pre-MBT Xenopus embryos independently of its catalytic function.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b948bbf8fb5cbdccfe5e4b4d6ad63b52"><gtr:id>b948bbf8fb5cbdccfe5e4b4d6ad63b52</gtr:id><gtr:otherNames>Dunican DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>866F491B3CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9FA7E26-7263-4A1C-80B7-C57D43D0304C</gtr:id><gtr:title>A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89294f6bf27bc4dafad391db6a16756e"><gtr:id>89294f6bf27bc4dafad391db6a16756e</gtr:id><gtr:otherNames>Katz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>Xock3jojzpZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFBE6CDF-2988-435D-A840-2DDF1A813EF5</gtr:id><gtr:title>The CXXC-TET bridge--mind the methylation gap!</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b948bbf8fb5cbdccfe5e4b4d6ad63b52"><gtr:id>b948bbf8fb5cbdccfe5e4b4d6ad63b52</gtr:id><gtr:otherNames>Dunican DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>pm_14263_23_23711677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A645EE1-6A14-4E90-A633-38955720B1CD</gtr:id><gtr:title>Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98548b7f0d172a12eb55f6751ffbd86e"><gtr:id>98548b7f0d172a12eb55f6751ffbd86e</gtr:id><gtr:otherNames>Cruickshanks HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_14263_23_23703216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB27B0DC-04EA-423A-9219-F41F7CBDBF76</gtr:id><gtr:title>Epigenetic reprogramming: preparing the epigenome for the next generation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40aa54e885d16be28d229d4d79a26d0"><gtr:id>f40aa54e885d16be28d229d4d79a26d0</gtr:id><gtr:otherNames>Rose CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_14263_23_23697942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12BA5C00-62E5-4BB1-8D5E-C994FE180F8E</gtr:id><gtr:title>Methylation-sensitive polymerase chain reaction.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e1160c335978b6e64d4a7436023e09b"><gtr:id>9e1160c335978b6e64d4a7436023e09b</gtr:id><gtr:otherNames>Moore HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5A4CAAB1735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36F837A1-DEE0-40F7-B605-E8E23E0984B5</gtr:id><gtr:title>Defending the genome from the enemy within: mechanisms of retrotransposon suppression in the mouse germline.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4acc8eba6022a30ee04f0e79be1fb53"><gtr:id>b4acc8eba6022a30ee04f0e79be1fb53</gtr:id><gtr:otherNames>Crichton JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>pm_14263_23_24045705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F511D7EE-18E5-4031-8C94-CD88074ED006</gtr:id><gtr:title>Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/beef200c9252b10229a52a6fd2b95d12"><gtr:id>beef200c9252b10229a52a6fd2b95d12</gtr:id><gtr:otherNames>Hackett JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>pm_14263_23_22949617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA810EFA-1BBC-4B4A-8B5C-D03F580C7C5B</gtr:id><gtr:title>Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion.</gtr:title><gtr:parentPublicationTitle>Toxicological sciences : an official journal of the Society of Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d3da3f0e8e527d9336211feeacb425b"><gtr:id>8d3da3f0e8e527d9336211feeacb425b</gtr:id><gtr:otherNames>Lempi?inen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1096-0929</gtr:issn><gtr:outcomeId>pm_14263_23_23091169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97A92980-9067-4B7C-B9ED-577452F7918C</gtr:id><gtr:title>Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_14263_23_23598998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A10D421C-6085-4E8E-87E0-62BCE41C177A</gtr:id><gtr:title>Cloning and expression of sheep DNA methyltransferase 1 and its development-specific isoform.</gtr:title><gtr:parentPublicationTitle>Molecular reproduction and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a209535e7da79b5d62367bda05695b6"><gtr:id>4a209535e7da79b5d62367bda05695b6</gtr:id><gtr:otherNames>Taylor J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1040-452X</gtr:issn><gtr:outcomeId>4C5B4347D94</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C295FFE7-D89D-45BD-98F8-16DA370DDCDA</gtr:id><gtr:title>DNMT1 deficiency triggers mismatch repair defects in human cells through depletion of repair protein levels in a process involving the DNA damage response.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050c0768d30fc7768438ba84c59db45e"><gtr:id>050c0768d30fc7768438ba84c59db45e</gtr:id><gtr:otherNames>Loughery JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>AnKh4HWYTJt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E6D317B-1226-4E63-942D-7148B3883765</gtr:id><gtr:title>LINE-1 activation and epigenetic silencing of suppressor genes in cancer: Causally related events?</gtr:title><gtr:parentPublicationTitle>Mobile genetic elements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4780f2bfc3988e5052d46989d75ca0a"><gtr:id>d4780f2bfc3988e5052d46989d75ca0a</gtr:id><gtr:otherNames>Tufarelli C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2159-2543</gtr:issn><gtr:outcomeId>542e75a3d57ef8.76468849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9552349D-2D60-40D9-A450-B6A21F4304CA</gtr:id><gtr:title>Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8325dbf499f9df455860713307706458"><gtr:id>8325dbf499f9df455860713307706458</gtr:id><gtr:otherNames>Nestor CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>J6YHccce3MF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF6CB72B-CF39-424B-B65D-3580F8553F19</gtr:id><gtr:title>Deep C diving: mapping the low-abundance modifications of the DNA demethylation pathway.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_14263_23_23732041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A0E9E5E-9EC7-4AA2-96D9-3954F96BA3FA</gtr:id><gtr:title>DNA methylation reprogramming in cancer: does it act by re-configuring the binding landscape of Polycomb repressive complexes?</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/385830da8e668f868ad41509c80b3eb9"><gtr:id>385830da8e668f868ad41509c80b3eb9</gtr:id><gtr:otherNames>Reddington JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>542e75a4403542.53631549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BAA4B60-3AEF-434C-93CB-059D81CBFB18</gtr:id><gtr:title>Epigenetic profiles as defined signatures of xenobiotic exposure.</gtr:title><gtr:parentPublicationTitle>Mutation research. Genetic toxicology and environmental mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1383-5718</gtr:issn><gtr:outcomeId>pm_14263_23_24001620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25511ED3-965A-4C52-BB49-86DE8BB710DF</gtr:id><gtr:title>Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_14263_23_23034186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5448A1B-A4F1-494A-A085-8BA98322520B</gtr:id><gtr:title>The non-methylated DNA-binding function of Kaiso is not required in early Xenopus laevis development.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a958836c63f12cd0a15e2066eb8fcb7"><gtr:id>8a958836c63f12cd0a15e2066eb8fcb7</gtr:id><gtr:otherNames>Ruzov A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>B7BA5C1B28C</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127574433</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>